Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
APN01-COVID-19
- Overall study
- Study Sites (2)
München
II. Medizinische Klinik und Poliklinik (Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie) TU München
Address
Ismaninger Straße 22
81675 München
Status
Active
Principal Investigator
Dr. Christoph Spinner
Contact at Site
- Dr. Christoph Spinner
- Tel. +49 (0)89 4140-5236
- Fax +49 (0)89 4140-7555
- christoph.spinner@mri.tum.de
1. Medizinische Klinik und Poliklinik & Ambulanzzentrum Infektiologie (UKE)
Address
Universitätsklinikum Hamburg Eppendorf (UKE)
Martinistr. 52
D-20246 Hamburg
Study office
Studienzentrum Sektion Infektiologie (UKE)
Status
Active
Principal Investigator
Dr. med. Stefan Schmiedel
Contact at Site
- Dr. med. Stefan Schmiedel
- Tel. +49 (0) 40 7410-0
- s.schmiedel@uke.de